Continued Integration of Daxor’s ezBVA Lab Service and On-Site Analyzers Fuels Positive Outlook ...

Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that it has entered into a ...

Who: hosted by the Canadian Health Coalition, Ontario Health Coalition, and the Ontario Federation of Labour.

Cowan will oversee clinical strategy, quality improvement, and expansion of multidisciplinary care teams ...

A $350 million initial term loan funded at closing, a portion of which was used to refinance Madrigal’s existing $115 million senior secured debt plus fees; A $150 million delayed draw term loan ...

NewAmsterdam will host a live webcast and conference call at 10:00 a.m. ET on July 30, 2025 to review the full AD biomarker data presented at AAIC. The call will include remarks from featured speakers ...

Topline results expected in the third quarter of 2025.

Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury and organ damage caused by inflammation. The Company is developing a platform of novel drugs ...

Phase 1 Data Highlight RE104 Favorable Safety Profile and Short Duration Psychoactive Experience ---- Topline Results from RECONNECT Phase 2 Trial of RE104 in Postpartum Depres ...

Amy and Kameel each bring an extraordinary combination of strategic vision, operational excellence, and hands-on experience developing and commercializing therapies in complex neurological and chronic ...

Board brings together diverse industry veterans representing insurers, educators, clinicians and healthcare providers to ensure a robust, practical approach to closing the autism support gap in ...

Management will be participating in one-on-one investor meetings throughout the conference. Investors interested in scheduling a meeting with the Rezolute management team should contact their BTIG ...